Parallax Volatility Advisers, L.P. Horizon Therapeutics Public LTD CO Put Options Transaction History

Parallax Volatility Advisers, L.P.

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $19.6 Million - $22.9 Million	-198,200 Reduced 71.29%	79,800 $9.23 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $23.9 Million - $27.9 Million	248,500 Added 842.37%	278,000 $28.6 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $42,928 - $45,400	400 Added 1.37%	29,500 $3.22 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $424,252 - $773,840	-6,800 Reduced 18.94%	29,100 $3.31 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1.53 Million - $2.2 Million	26,000 Added 262.63%	35,900 $2.22 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $423,458 - $538,069	4,900 Added 98.0%	9,900 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $4.55 Million - $5.46 Million	-49,500 Reduced 90.83%	5,000 $548,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $431,200 - $479,600	5,000 Added 10.1%	54,500 $5.1 Million
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $3.56 Million - $4.73 Million	49,500 New	49,500 $4.56 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $556,100 - $700,437	-8,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $458,409 - $663,419	8,300 New	8,300 $645,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.